Mami Shibata‐Koyama

Author

Mami Shibata‐Koyama

Also Known As

M. Shibata-Koyama, Mami Shibata-Koyama, Mami Shibata‐Koyama

Publications

607

Citations

H-Index

Concepts

All Affiliations

Mami Shibata‐Koyama is an author at Kyowa Kirin (Japan) specializing in immunology, medicine, and immunotherapy.

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	353
2	Natural Sciences	1	1	239
3	Allergy	1	1	114
4	Biochemistry	1	1	239
5	Cell Biology	1	1	239

Mami Shibata‐Koyama

Publications

607

Citations

H-Index

Page 1

	Year	Citations
Structural basis for improved efficacy of therapeutic antibodies on defucosylation of their Fc glycans Tsunehiro Mizushima, Hirokazu Yagi, Emi Takemoto, Genes to Cells Crystal StructureGlycobiologyImmunologyImmunotherapeuticsAnalytical Ultracentrifugation	2011	239
A Nonfucosylated Variant of the anti-HIV-1 Monoclonal Antibody b12 Has Enhanced FcγRIIIa-Mediated Antiviral Activity <i>In Vitro</i> but Does Not Improve Protection against Mucosal SHIV Challenge in Macaques Brian Moldt, Mami Shibata‐Koyama, Eva G. Rakasz, Journal of Virology	2012	116
Nonfucosylated rituximab potentiates human neutrophil phagocytosis through its high binding for FcγRIIIb and MHC class II expression on the phagocytotic neutrophils Mami Shibata‐Koyama, Shigeru Iida, Hirofumi Misaka, Experimental Hematology InflammationImmune Effector FunctionsMicrobial PathogensAllergyHigh Binding	2009	114
The N-linked oligosaccharide at Fc RIIIa Asn-45: an inhibitory element for high Fc RIIIa binding affinity to IgG glycoforms lacking core fucosylation Mami Shibata‐Koyama, S. Iida, Akira Okazaki, Glycobiology	2008	112
Importance of the Side Chain at Position 296 of Antibody Fc in Interactions with FcγRIIIa and Other Fcγ Receptors Yuya Isoda, Hirokazu Yagi, Tadashi Satoh, PLoS ONE	2015	26

Page 1